Lung Disease and Hypertension

Yuki Imaizumi, Kazuo Eguchi, Kazuomi Kario

PULSE · 2014-yil

Annotatsiya

Chronic obstructive pulmonary disease (COPD) patients are at a high risk of developing cardiovascular diseases. Airflow limitation is a predictor of future risks of hypertension and cardiovascular events. COPD is now understood as a systemic inflammatory disease, with the focus on inflammation of the lungs. An association between inflammation and sympathetic overactivity has also been reported. In this article, we review the association between chronic lung disease and the risks of hypertension, cardiovascular morbidity, the underlying mechanisms, and the therapeutic approach to hypertension and cardiovascular diseases in patients with lung diseases.

Maqola ma’lumotlari
MualliflarYuki Imaizumi, Kazuo Eguchi, Kazuomi Kario
JurnalPULSE
Nashr sanasi2014-01-01
Jild2
Son1-4
Betlar103-112
Tilen
DOI10.1159/000381684

PULSE jurnalidan boshqa maqolalar

PULSE — barcha maqolalar